Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04587687
Title Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Joseph Tuscano
Indications

follicular lymphoma

Therapies

Bendamustine + Brentuximab vedotin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.